Notice Title

Consent to the Distribution of New Medicines

Publication Date
14 Nov 2024

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2024-go5762
Title
View PDF
File Type and Size
PDF (33 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Volibris
Active Ingredient: Ambrisentan 5mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: Patheon Inc, Mississauga, Canada
   
Product: Volibris
Active Ingredient: Ambrisentan 10mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturer: Patheon Inc, Mississauga, Canada


Dated this 8th day of November 2024.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).